Acinetobacter baumannii DSM 101993 is a mesophilic prokaryote that has multiple antibiotic resistances.
antibiotic resistance mesophilic genome sequence| @ref 20215 |
Last LPSN update
2025-12-16 10:07:54 |
| Domain Pseudomonadati |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Moraxellaceae |
| Genus Acinetobacter |
| Species Acinetobacter baumannii |
| Full scientific name Acinetobacter baumannii Bouvet and Grimont 1986 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 64488 | LB (Luria-Bertani) MEDIUM (DSMZ Medium 381) | Medium recipe at MediaDive  | Name: LB (Luria-Bertani) MEDIUM (DSMZ Medium 381) Composition: Agar 20.0 g/l NaCl 10.0 g/l Tryptone 10.0 g/l Yeast extract 5.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | Range | |
|---|---|---|---|---|---|
| 64488 | positive | growth | 37 | mesophilic |
| @ref | Biosafety level | Biosafety level comment | |
|---|---|---|---|
| 64488 | 2 | Risk group (German classification) |
Phages| @ref | Name | Strain number | |
|---|---|---|---|
| 124042 | Acinetobacter phage vB_AbaM-Bhz12 | DSM 101993 | |
| 124042 | Acinetobacter phage vB_AbaM-Bhz23 | DSM 101993 |
| @ref | Description | Assembly level | INSDC accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|
| 124043 | ASM4506449v1 assembly for Acinetobacter baumannii DSM 101993 | contig | GCA_045064495   | 470 | 74.52 |  |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Phage Therapy for Hospital-Acquired Respiratory Bacterial Infections: A Review Fagoterapia para infecciones respiratorias bacterianas de adquisición nosocomial: revisión de la literatura | Munoz-Egea M, Rodriguez A, Esteban J, Garcia-Quintanilla M. | Open Respir Arch | 2025 | | ||
| Biological Properties of 12 Newly Isolated Acinetobacter baumannii-Specific Bacteriophages. | Baginska N, Harhala MA, Cieslik M, Orwat F, Weber-Dabrowska B, Dabrowska K, Gorski A, Jonczyk-Matysiak E. | Viruses | 10.3390/v15010231 | 2023 | | |
| The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections. | Garcia-Patino MG, Garcia-Contreras R, Licona-Limon P. | Front Immunol | 10.3389/fimmu.2017.00441 | 2017 | | |
| Metabolism | Modulating Isoprenoid Biosynthesis Increases Lipooligosaccharides and Restores Acinetobacter baumannii Resistance to Host and Antibiotic Stress. | Palmer LD, Minor KE, Mettlach JA, Rivera ES, Boyd KL, Caprioli RM, Spraggins JM, Dalebroux ZD, Skaar EP. | Cell Rep | 10.1016/j.celrep.2020.108129 | 2020 | |
| Lytic bacteriophages as alternative to overcoming antibiotic-resistant biofilms formed by clinically significant bacteria. | Osman AH, Darkwah S, Kotey FCN, Asante-Poku A, Donkor ES. | Ther Adv Infect Dis | 10.1177/20499361251356057 | 2025 | | |
| Pathogenicity | Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of Acinetobacter baumannii from Croatia. | Goic-Barisic I, Bedenic B, Tonkic M, Novak A, Katic S, Kalenic S, Punda-Polic V, Towner KJ. | J Clin Microbiol | 10.1128/jcm.02394-08 | 2009 | |
| Diversity and evolution of AbaR genomic resistance islands in Acinetobacter baumannii strains of European clone I. | Krizova L, Dijkshoorn L, Nemec A. | Antimicrob Agents Chemother | 10.1128/aac.00221-11 | 2011 | | |
| Pathogenicity | Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia. | Dietert K, Gutbier B, Wienhold SM, Reppe K, Jiang X, Yao L, Chaput C, Naujoks J, Brack M, Kupke A, Peteranderl C, Becker S, von Lachner C, Baal N, Slevogt H, Hocke AC, Witzenrath M, Opitz B, Herold S, Hackstein H, Sander LE, Suttorp N, Gruber AD. | PLoS One | 10.1371/journal.pone.0188251 | 2017 | |
| Phylogeny | Sequence-based typing of ade B as a potential tool to identify intraspecific groups among clinical strains of multidrug-resistant Acinetobacter baumannii. | Huys G, Huys G, Cnockaert M, Nemec A, Swings J. | J Clin Microbiol | 10.1128/jcm.43.10.5327-5331.2005 | 2005 | |
| Phylogeny | O-antigen diversity among Acinetobacter baumannii strains from the Czech Republic and Northwestern Europe, as determined by lipopolysaccharide-specific monoclonal antibodies. | Pantophlet R, Nemec A, Brade L, Brade H, Dijkshoorn L. | J Clin Microbiol | 10.1128/jcm.39.7.2576-2580.2001 | 2001 | |
| Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. | Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. | Clin Microbiol Rev | 10.1128/cmr.00058-16 | 2017 | | |
| The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. | Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. | PLoS One | 10.1371/journal.pone.0010034 | 2010 | | |
| Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. | Dijkshoorn L, Aucken H, Gerner-Smidt P, Janssen P, Kaufmann ME, Garaizar J, Ursing J, Pitt TL. | J Clin Microbiol | 10.1128/jcm.34.6.1519-1525.1996 | 1996 | | |
| Pathogenicity | Preclinical Assessment of Bacteriophage Therapy against Experimental Acinetobacter baumannii Lung Infection. | Wienhold SM, Brack MC, Nouailles G, Krishnamoorthy G, Korf IHE, Seitz C, Wienecke S, Dietert K, Gurtner C, Kershaw O, Gruber AD, Ross A, Ziehr H, Rohde M, Neudecker J, Lienau J, Suttorp N, Hippenstiel S, Hocke AC, Rohde C, Witzenrath M | Viruses | 10.3390/v14010033 | 2021 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive157916.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License